Home » Topics » Regulatory

Regulatory
RSS

Adapalene and pharmaceutical compositions thereof for use in cancer therapy

Sep. 17, 2001

Pump therapy with insulin aspart approved by EMEA

Sep. 14, 2001

Plavix sNDA granted FDA priority review

Sep. 13, 2001

Allergan's Botox cleared in Canada for treatment of axillary hyperhidrosis

Sep. 13, 2001

FDA approves Xeloda/Taxotere combination therapy for metastatic breast cancer

Sep. 13, 2001

Further submissions announced for Visudyne

Sep. 13, 2001

Novartis, QLT seek approval for expanded use of Visudyne in E.U.

Sep. 12, 2001

Janssen seeks FDA approval of new long-acting Risperdal formulation

Sep. 10, 2001

Ortec's OrCel approved for healing donor site wounds in burn victims

Sep. 10, 2001

Pariet receives E.U. clearance for treatment of symptomatic GERD

Sep. 7, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 19, 2025.
Skyhawk’s small-molecule RNA efforts draw Merck KGaA in $2B deal
BioWorld
Adding another name to an impressive roster of partners assembled over the past few years, Skyhawk Therapeutics Inc. inked a neurology-focused deal with Merck...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Aug. 19, 2025.
CSL to shave off 3,000 jobs, Seqirus vaccine unit
BioWorld
CSL Ltd.’s stock tumbled 16.88% on the news that it plans to cut 3,000 jobs and to hive off its Seqirus vaccine unit in a cost-cutting measure to save more than...
GI blow: Viking soldiers on with midstage oral obesity bid
BioWorld
Rates of adverse events (AEs) gave pause to some on Wall Street, and shares of Viking Therapeutics Inc. (NASDAQ:VKTX) fell 42%, or $17.73, to close Aug. 19 at...